Control of neuroprotection through NMDA receptor-dependent regulation of antioxidant status.
In plain English
AI plain-English summaryA single brain receptor, the NMDA receptor, can either keep neurons alive or kill them, depending on how strongly it is activated. This creates a fundamental problem for treating stroke and neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS. Too little NMDA receptor activity harms brain development, as seen in Foetal Alcohol Syndrome. Too much activity kills neurons during a stroke or in certain neurodegenerative conditions. Yet blocking the receptor outright with drugs is also harmful—the brain needs a moderate level of its activity to survive. The researchers aim to map the specific survival signals triggered by low-level NMDA receptor activation, and then find ways to block only the deadly downstream consequences of overactivation, leaving the receptor itself untouched. If successful, this work could identify new therapeutic targets for stroke—a condition where blood supply to the brain is cut off—and potentially for neurodegenerative diseases. The project also uses stem cell-derived human neurons, which provide a theoretically limitless supply of cells that may better reflect human disease biology than animal models. This is primarily fundamental science: understanding how the brain’s natural neuroprotective mechanisms work, and why they fail.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
FellowshipPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know